Bibliography of Dr Ram

Bibliography

Dr. Ram is a renowned High Blood Pressure Expert and Hypertension Specialist committed to providing advanced and personalized care for patients with elevated blood pressure. He specializes exclusively in hypertension management, focusing on accurate diagnosis, tailored treatment plans, and long-term monitoring. His holistic approach combines modern medicine with lifestyle guidance to prevent serious complications such as heart disease, stroke, and kidney failure. With a strong emphasis on preventive care, Dr. Ram helps patients achieve stable blood pressure and improved quality of life. His expertise, compassion, and results-driven approach make him a trusted name in hypertension care.

Dr.Ram
MD, MACP, FACC, FASH

Contact Dr Ram

1976

1977

Ram CVS. Newer antihypertensive drugs. Heart and Lung 6(4):679-84, 1977
Ram CVS, Kaplan NM. Systolic hypertension. Practical Cardiology 3:17, 1977.
Ram CVS, Reichgott MJ. Treatment of loop-diuretic resistant edema by the addition of metolazone. Current Therapeutic Research 2:686, 1977.
Reichgott MJ, Ram CVS. Synergism between metolazone and loop-diuretics. Clinical Research 25:275A, 1977.

1978

Ram CVS. Hypertensive encephalopathy – recognition and management. Archives of Internal Medicine 138(12):1851-1853, 1978.
Ram CVS, Kaplan NM. Diuretics and sodium restriction in the treatment of hypertension: effects on potassium wastage and blood pressure control (Abstract). Circulation 58:II-164, 1978.
Ram CVS, Reichgott MJ. Fluid retention with minoxidil (Letter). Annals of Internal Medicine 89(2):288-289, 1978.
Reichgott MJ, Ram CVS. Relationship of hypertension to heart failure: functional and pharmacological considerations. Pennsylvania Medicine 81(2):50-52, 1978

1979

Anderson RJ, Ram CVS, Kaplan NM. Abrupt discontinuation of clonidine therapy; monitoring the blood pressure changes in outpatients with a semi-automatic blood pressure recording device (Abstract). Clinical Research 27:311A, 1979
Pillai VK, Ram CVS, Kokko JP. Evidence of direct participation of central alpha-adrenergic receptors in the release of ADH: studies with clonidine and norepinephrine (Abstract). Clinical Research 27:237A, 1979.
Ram CVS. Clinical applications of beta-adrenergic blocking drugs – a growing spectrum. Heart and Lung 8(1):116-123, 1979.
Ram CVS, Engelman K. Abrupt discontinuation of clonidine: a prospective study. Clinical Pharmacology and Therapeutics 25:243, 1979.
Ram CVS, Engelman K. Abrupt discontinuation of clonidine therapy. Journal of the American Medical Association 242(19):2104-2105, 1979
Ram CVS, Engelman K. Pheochromocytoma: pathophysiology, recognition and management. Current Problems in Cardiology 4(1):1-37, 1979.
Ram CVS, Holland OB, Fairchild C, Gomez-Sanchez CE. Withdrawal syndrome following cessation of guanabenz therapy. Journal of Clinical Pharmacology 19(2-3):148-150, 1979.
Ram CVS, Holland OB, Kaplan NM. Clinical evaluation of amiloride, a new potassium sparing diuretic (Abstract). Clinical Research 27:237A, 1979
Ram CVS, Kaplan NM. Alpha and beta-receptor blocking drugs in the treatment of hypertension. Current Problems in Cardiology 3(10):1-53, 1979.
Ram CVS, Kaplan NM. Assessment of 24-hour blood pressure control during once-a-day administration of antihypertensive therapy. Clinical Pharmacology and Therapeutics 24:243, 1979.
Ram CVS, Kaplan NM. Individual titration of didazoxide dosage in the treatment of severe hypertension. American Journal of Cardiology 43(3):627-630, 1979.

1980

1981

Ram CVS. Diuretics in the treatment of hypertension. Hospital Formulary 16:741, 1981.
Ram CVS. Hypertensive encephalopathy. Consultant 21(1):177, 1981.
Ram CVS. Primary aldosteronism – its role in hypertension. Consultant 21(12):211, 1981.
Ram CVS, Anderson RJ, Hart GR, Crumpler CP. Alpha-adrenergic blockade by Prazosin in therapy of essential hypertension. Clinical Pharmacology and Therapeutics 29(6):719-722, 1981.
Ram CVS, Carnegie A, Kaplan NM. Inhibitors of the renin angiotensin system plus a diuretic in the treatment of hypertension: effects on potassium and blood pressure (Abstract). Clinical Research 29(2):525A, 1981.
Ram CVS, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension: Effects of potassium wastage and blood pressure control. Archives of Internal Medicine 141(8):1015-1019, 1981.
Ram CVS, Holland OB, Kaplan NM. Attenuation of diuretic-induced hypokalemia by amiloride, a potassium-sparing agent. Journal of Clinical Pharmacology 21(11-12 Pt 1):484-487, 1981.

1982

Ram CVS. Antihypertensive medication in the elderly (letter). Journal of the American Medical Association 248(6):647, 1982.
Ram CVS. Captopril. Archives of Internal Medicine 142(5):914-16, 1982.
Ram CVS. Captopril in the treatment of hypertension. Texas Medicine 78:38-41, 1982.
Ram CVS. Clinical applications of therapeutic advances: captopril. Archives of Internal Medicine 142:914-916, 1982.
Ram CVS. Diuretics in the management of hypertension. Postgraduate Medicine 71(2):155-159, 162-168, 1982.
Ram CVS. Hypertension control today – an appraisal and reappraisal. Texas Medicine 78(8):6-7, 1982.
Ram CVS. Hypertensive crisis. IN: Velasco M, (ed.) Pharmacology and Therapeutics, International Congress Series 604, Amsterdam: Excerpta Medica 1982:454-459.
Ram CVS. Hypertensive emergencies – recognition and management. Current Problems in Cardiology. 7(1):7-70, 1982.
Ram CVS. Primary aldosteronism. Comprehensive Therapy 8(11):60-68, 1982.
Ram CVS, Helderman H. Hypertension associated with renal parenchymal disease. Practical Cardiology 8(11):86, 1982.

1983

Brater DC, Anderson SA, Kaplan NM, Ram CVS. Effects of atenolol, nadolol and propranolol on renal haemodynamics. New Zealand Medical Journal 96:833-6, 1983.
Ram CVS. Hypertensive crises: Primary Care 10(1):41-61, 1983.
Ram CVS. Hypertensive crises – Part 1:Causes. Journal of Cardiovascular Medicine 8:645, 1983
Ram CVS. Hypertensive crises – Part 2: Causes. Journal of Cardiovascular Medicine 8(7):781, 1983.
Ram CVS. Hypertensive crises – Part 3: Drug Treatment. Journal of Cardiovascular Medicine 8(8):917, 1983.
Ram CVS. Hypertensive emergencies. In: Martinez-Maldonado M ed. Handbook of Renal Therapeutics. New York: Plenum Medical Company, 1983.
Ram CVS. Initial evaluation of the patient with hypertension. Practical Cardiology 9(5):39, 1983.
Ram CVS. Management of essential and secondary hypertension. In: Martinez-Maldonado M ed. Handbook of Renal Therapeutics. New York: Plenum Medical Company, 1983.
Ram CVS. Renovascular hypertension: When to suspect it. Diagnosis 1983;January:40-48.
Ram CVS. Should mild hypertension be treated? (editorial). Annals of Internal Medicine 99(3):403-405, 1983.
Ram CVS, Anderson S, Simmons M, Kaplan NM and Brater DC. Effects of beta-blockade on renal functions (Abstract). Clinical Research 31:439A, 1983.
Ward P, Ram CVS. Methyldopa and hydralazine interaction in the treatment of severe hypertension (Abstract). Clinical Research 31:333A, 1983.

1984

Brater DC, Anderson S, Kaplan NM, Ram CVS. Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives. Journal of Hypertension 2(1):43-48, 1984.
Garrett BN, Ram CVS. Acute aortic dissection. Cardiology Clinics 2(2):227-238, 1984.
Garrett BN, Ram CVS, Kaplan NM. Effect of pindolol on potassium homeostasis in patients with essential hypertension. Clinical Therapeutics 6(4):524-535, 1984.
Ram CVS. Clinical considerations in combination drug therapy of hypertension. Practical Cardiology 10(5):83-105, 1984.
Ram CVS. Hypertensive crisis. Cardiology Clinics 2(2):211-225, 1984.
Ram CVS. Should mild hypertension be treated? Choosing the middle course. Medical Clinics of North America 68(2):469-476, 1984.
Ram CVS (guest editor). Symposium on Cardiovascular Emergencies. Cardiology Clinics. Philadelphia: W.B. Saunders, 2(2), 1984.
Ram CVS, Carnegie AL, Kaplan NM. Effect of nitrendipine therapy on ambulatory blood pressure. In: Scribiane A, Vanov S, Deck K eds. Nitrendipine. Baltimore: Urban and Schwarzenberg, 1984:501.
Ram CVS, Johnson R, Carnegie A, Dhaliwal H. Potassium depletion and repletion in hypertension. Effects on blood pressure, vascular reactivity, renin and aldosterone (Abstract). Clinical Research 32(2):337A, 1984.
Ram CVS, Kaplan NM. Hypertensive emergencies. IN: Shoemaker WC, Thompson WL, Holbrook PR eds. Textbook of Critical Care. Philadelphia: W.B. Saunders Company, 1984. Ram CVS, Kaplan NM, Carnegie A. Treatment of hypertension with a new calcium blocker nitrendipine. Effects with once or twice a day dosage and with or without a diuretic (Abstract). Proceedings of the 10th Scientific Meeting of the International Society of Hypertension, #722, 1984.
Ram CVS, Punzi HA, Chia BL. Three agents for resistant hypertension: how do they compare? Modern Medicine 52(9):88-105, 1984
Schoenberger JA, Glasser SP, Ram CVS, McMahon SG, Vanov SK, Leibowitz DA. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate hypertension. Journal of Cardiovascular Pharmacology 6(Suppl 7):S1105-S1108, 1984.

1985

Meese RB, Ram CVS. Hypertensive cardiovascular emergencies. Comprehensive Therapy 11(10):28-38, 1985.
Ram CVS. Calcium antagonists in the treatment of hypertension. American Journal of Medical Science 290(3):118-132, 1985.
Ram CVS, Meese RB, Hill SC. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma. Archives in Internal Medicine 145(11):2114-2115, 1985.
Schafer S, Ram CVS. The heart in hypertension, physiological and pharmacological implications. Practical Cardiology 11:80, 1985.

1986

Ram CVS. Changing trends in the treatment of congestive heart failure ad hypertension – reassessment of the role of diuretics. Advances in Therapy 3:149-156, 1986.
Ram CVS, Kaplan NM. Use of diuretics in hypertension. In: Eknoyan G, Martinez-Maldonado M (eds.). The Physiological Basis of Diuretic Therapy. Florida: Grune & Stratton, 1986:211-224.
Ram CVS. Antihypertensive action also preserves renal function. In: Nicardipine: A vasuselective calcium antagonist. Symposium highlights, Washington D.C. Syntex; 1986: 4-5.

1987

Featherston WE, Ram CVS. Secondary causes of hypertension – health and cost benefits of making these diagnoses. Consultant 27(8):109-117, 1987.
Gonzalez DG, Ram CVS. Antihypertensive therapy in coronary artery disease. Geriatrics 42(12):45-50, 1987.
Gonzalez DG, Ram CVS. Therapeutic survey: hypertensive emergencies. Canadian Journal of Cardiology 3(4):154-161, 1987.
Meese RB, Gonzalez DG, Casparian JM, Ram CVS, Pak CYC, Kaplan NM. The inconsistent effects of calcium supplements upon blood pressure in primary hypertension. American Journal of Medical Sciences 294(4):219-224, 1987
Ram CVS. Calcium antagonists as antihypertensive agents are effective in all age groups. Journal of Hypertension 5(Suppl 4):S115-S118, 1987.
Ram CVS. Calcium antagonists in the treatment of hypertension – an overview and implications. Journal Islamic Medical Association 19:36-40, 1987.
Ram CVS. Changing trends in the treatment of hypertension: role of diuretic reassessed. In: Puschett JB ed. Diuretics II: Chemistry, Pharmacology and Clinical Applications. New York: Elsevier, 1987:577-585.
Ram CVS. Hypertensive cardiac hypertrophy. Cardio August, 1987:58-60.
Ram CVS. Hypertensive crises. In: Kaplan NM, Brenner BM, Laragh JH eds. Perspectives in Hypertension, Volume 1: The Kidney in Hypertension. New York: Raven Press. 1987:197-212.
Ram CVS. Management of resistant hypertension. Chest 92(6):1096-1097, 1987
Ram CVS. Nicardipine for systemic hypertension: effects on blood pressure and target organ function. American Journal of Cardiology 59:25J-30J, 1987.
Ram CVS, Gonzalez D. Drug treatment of hypertension: expanding the role of calcium antagonists. Therapaeia January/February:6-12, 1987.
Ram CVS, Gonzalez D. Geriatric hypertension: antihypertensive therapy in coronary artery disease. Geriatrics 42(12):45-7, 50, 1987.
Ram CVS, Gonzalez DG, Kaplan NM et al. Renal hemodynamic effects of ketanserin therapy in essential hypertension. Journal of Cardiovascular Pharmacology 10(Suppl 3):S78-S80, 1987.
Ram CVS, Hyman D. Hypertensive crises. Journal of Intensive Care Medicine 2:151-162, 1987.
Ram CVS, Meese RB, Kaplan NM et al. Antihypertensive therapy in the elderly: effects on blood pressure and cerebral blood flow. American Journal of Medicine 82(Suppl 1A):53-57, 1987.

1988

Boldrick RW, Ram CVS. Causes and management of refractory hypertension. Cardiovascular Reviews and Reports 9(2):39-42, 1988.
Burris JF, Ames RP, Applegate WB, Ram CVS, Davidov ME, Mroczek WJ. Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 12(Suppl 7):S98-S102, 1988.
Ram CVS. Ketanserin in essential hypertension: effects on blood pressure and on renal hemodynamics. American J Hypertension 1:309S-311S, 1988.
Ram CVS. Malignant hypertension. Acute Care Therapeutics 3(2):1-3, 1988.
Ram CVS. Management of refractory hypertension. Diagnosis 10(9):83-90, 1988.
Ram CVS. Pheochromocytoma. Cardiology Clinics 6(4): 517-535, 1988.
Ram CVS. Renovascular hypertension. Cardiology Clinics 6(4):483-508, 1988.
Ram CVS. Therapy of malignant hypertension. Acute Care Therapeutics 3(2):4-11, 1988.
Ram CVS. Treatment of hypertension in renal failure. In: Davison AM, Briggs JD, Green R et al eds. Nephrology, Volume 11: Proceedings of the Xth International Congress of Nephrology. London: W.B. Saunders, 1988:907-916.
Ram CVS. Work-up for secondary hypertension: why, when and how much? Cardiology Clinics 6(4):465-66, 1988.
Ram CVS, Featherston WE. Calcium antagonists in the treatment of hypertension. Chest 93:251-53, 1988.
Ram CVS, Gonzalez D. New approaches for the treatment of hypertensive urgencies and emergencies. Chest 93:193-195, 1988.
Ram CVS, Heller JA. Malignant hypertension – a case study. Acute Care Therapeutics 3(2):12-13, 1988.
Ram CVS. Effects of nicarodipine therapy on blood pressure and on target organ function. In: Aoki K, Buhler F eds. 2nd International Symposium on Hypertension 1988. Nagoya, Japan: 1988; p30

1989

Lessem JN, Barone EJ, Bert T et al. Nicardipine and propranolol in the treatment of essential hypertension. Am J Hypertens 2:146-153, 1989.
Ram CVS. Beta blockers in the treatment of hypertension – rationale and application. Cardio 1989.
Ram CVS. Beta blocker therapy for hypertension. Cardio (February) 1989:114-116, 118, 162.
Ram CVS. High blood pressure, severe hypokalemia (Comment) Patient Care 23(4):115, 1989.
Ram CVS. Hypertension case and comment. (Comment) Patient Care 23(6):187-8, 90, 1989.
Ram CVS. Left ventricular hypertrophy in patients: clinical significance and therapeutic implications. Cardiopulmonary News and Interviews 3(4):8-10, 1989.
Ram CVS. Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications. Journal of Hypertension 7(Suppl 6):S98-S99, 1989.
Ram CVS. Severe hypertension in the elderly. In: Martinez-Maldonado M ed. Hypertension and Renal Disease in the Elderly. Cambridge, Massachusetts: Blackwell Scientific Publications, 1989.
Ram CVS, Boldrick RW, Heller J et al. Rapid control of severe hypertension with intravenous infusion of nicardipine – a new therapeutic approach. Journal of Clinical Pharmacology 29:835, 1989.
Ram CVS, Gonzalez D, Kulkarni P et al. Regression of left ventricular hypertrophy in hypertension: effects of prazosin therapy. American Journal of Medicine 86(1B):66-69, 1989.
Ram CVS, Tjoa HI. Ca++ blockers: antisclerotic, anti-calcinotic effects. Cardio (August), 1989:110-112.
Wallin JD, Fletcher E, Ram CVS et al. Intravenous nicardipine for the treatment of severe hypertension. Archives of Internal Medicine 149:2662-2669, 1989.
Ram CVS. Current Management of the Hypertensive Diabetic. 36th Postgraduate Course: Great Debates in Diabetes. Am Diabetes Assoc. 1989:pgs 102-123.

1990

Ram CVS. Anti-atherosclerotic and vasculoprotective effects of calcium antagonists: clinical implications. Journal of Human Hypertension 4(Suppl 5):35-39, 1990.
Kaplan NM, Ram CVS. Potassium supplements for hypertension. New England Journal of Medicine 322:623-24, 1990.
Ram CVS. Anti-atherosclerotic and vasculoprotective actions of calcium antagonists. American Journal of Cardiology 66:29I-32I, 1990.
Ram CVS. Anti-atherosclerotic and vasculoprotective effects of calcium antagonists: clinical implications. Journal Human Hypertension 4(Suppl 5):35-39, 1990.
Ram CVS. Combined use of angiotensin converting enzyme inhibitors and diuretics in the treatment of hypertension – physiological basis and clinical implications. IN: Puschett JB, Greenberg A eds. Diuretics III: Chemistry, Pharmacology and Clinical Applications. New York: Elsevier, 1990:440-46
Ram CVS. Current concepts in the diagnosis and management of hypertensive urgencies and emergencies. Keio Journal of Medicine 39(4):225-36, 1990.
Ram CVS. Vascular protection and antiatherogenic effects of calcium antagonists. Practical Cardiology October:27-28, 1990.
Ram CVS, Gonzalez DG, Featherston W et al. Nicardipine and propranolol in the treatment of hypertension: similar antihypertensive but dissimilar hemodynamic actions. American Heart Journal 119:463-8, 1990.

1991

Feit A, Cohen M. Dimino L, el-Sherif N, Holtzman R, Ram CVS, Gaffney D, Heller J, Kaplan NM. The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients. Journal of Human Hypertension 5(1):39-43, 1991.
Ram CVS. Diagnosis and management of hypertensive crises. In: Rippe JM, Irwin RS, Alpert JS, Fink MP eds. Intensive Care Medicine 2nd Edition. Boston, Little, Brown and Company, 1991:228-38.
Ram CVS. Hypertension and atherosclerosis. In: Boone JL ed. Primary Care 18(3):559-75, 1991.
Ram CVS. Management of hypertension emergencies: changing therapeutic options. American Heart Journal 122 (1 pt 2):356-63, 1991.

1992

Ram CVS. Clinical assessment and management of mild to severe hypertension in the elderly. In: Martinez, Maldonado M ed. Hypertension and Renal Disease in the Elderly. Boston: Blackwell Scientific Publications 1992:144-160.
Ram CVS. Clinical manifestations and treatment of hypertensive emergencies. AKF Nephrology Letter 9(1):1-11, 1992.
Ram CVS. Current concepts in renovascular hypertension. American Journal of the Medical Sciences 304:53-71, 1992.
Ram CVS. Hypertension called key risk in atherosclerosis. American College of Chest Physicians 57th Annual Scientific Assembly, San Francisco, Medical Meeting Highlights. Healthcare Professional Publishing, 1992:2-3.
Ram CVS. Hypertensive crises: lifesaving treatment for emergencies and urgencies. Consultant 32(8):46-54, 1992.
Ram CVS. Chapter 10: Hypertensive emergencies. In: Carlson RW, Reines HD eds. Critical Care. State of the Art. California: Society of Critical Care Medicine 1992:207-34.
Ram CVS. Communicating with patients about their medications (Letter). New England Journal of Medicine 327(2):131-2, 1992.
Ram CVS, Khoury AS. Hypertensive Emergencies. In: Cooke JP, Frohlich ED eds. Current Management of Hypertensive and Vascular Diseases. Missouri: Mosby-Year Book, Inc., 1992:35-48.

1993

Frishman WH, Ram CVS, McMahon FG, Chrysant SG, Graft A, Kupiec JW, Hsu H. Comparison of amlodipine and benazepril monotherapy to combination therapy in patients with systemic hypertension: a randomized, double-blind placebo-controlled, parallel group study. Clin Cardio 1993.
Neutel JM, Smith DH, Ram CVS, Lefkowitz MP, Kazempour MK, Weber MA. Comparison of bisoprolol with atenolol for systemic hypertension in four population groups (young, old black and non-black) using ambulatory blood pressure monitoring. Bisoprolol Investigators Group. American Journal of Cardiology 1993; 72:41-46.
Neutel JM, Smith DHG, Ram CVS, Kaplan NM, Papademetriou V, Fagan TC, Lefkowitz MP, Weber MA. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. Am J Med 1993; 94:181-187.
Ram CVS. Adrenergic mechanisms in left ventricular hypertrophy: significance and clinical implications. Indian Heart Journal 1993;45:21-24.
Ram CVS. Adrenergic mechanisms in left ventricular hypertrophy: significance and clinical implications. Journal Clin Pharmaco 1993; 33:887-891.
Ram CVS. Antiatherosclerotic effects of calcium-channel blockers: therapeutic implications. Cardio March 1993:77-83.
Ram CVS. Hypertension specialist looks beyond simple control of hypertension (Newsletter). “In Person” 1993;7(1):2, published by Hoechst-Roussel Pharmaceuticals Inc.
Ram CVS. Management of hypertension in the elderly patient with CHF. Clinical Geriatrics 1993; 1(5):20-29.
Ram CVS. Managing hypertensive emergencies and urgencies. Contemporary Internal Medicine 1993; 5(8):19-32.
Ram CVS. Therapeutic options in the management of hypertension: Reemerging focus on alpha blockers. Indian Heart Journal 1993; 45:81-85.
Ram CVS. Vasodilators. In: Taubert KA, Izzo JL, Black H eds. Hypertension Primer. Dallas, Texas: American Heart Association, 1993.
Neutel JM, Smith DH, Ram CV, Kaplan NM, Papdemetriou V, Fagan TC, et al. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. Am J Med 1993; 94: 181-187.

1994

Agarwal R, Ram CVS. Diuretics. In: Singh BN, Dzau VJ, Vanhoutte PM, Woosley RL eds. Cardiovascular Pharmacology and Therapeutics. New York: Churchill Livingstone, 1994:353-368.
Amsterdam EA, Mathews JJ, Messerli FH, Pitts S, Ram CVS. Urgent, emergent – and safe – BP reduction. Patient Care 28(14):80-111, 1994.
Kaplan NM, Ram CVS. Hypertension in ethnic subgroups. In: Swales JD ed. Textbook of Hypertension. Oxford: Blackwell Scientific Publications, 1994:811-828. Kaplan NM, Ram CVS. Individualized Therapy of Hypertension. New York: Marcel Dekker, Inc., 1994.
Neutel JM, Smith DHG, Wallin D, Cook E, Ram CVS, Fletcher E, Maher KE, Turlapaty P, Grundy S, Lee R, Weber MA. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. American Journal of Hypertension 7:6 23-28, 1994.
Ram CVS. Hypertensive crises. In: Kaplan NM, Ram CVS eds. Individualized Therapy of Hypertension. New York: Marcel Dekker, Inc., 1994:223-244.
Ram CVS. Recognition and management of hypertensive urgencies and emergencies: current therapeutic options. In: Parker MM ed. 1994 Educational and Scientific Symposium-Symposia Highlights. Pennsylvania/California: Medical Association Communications/Society of Critical Care Medicine, 1994:5-6.
Ram CVS. Renoprotective effects of ACE inhibitors. In: “Beyond Blood Pressure Control…Cardiovascular consequences of ACE inhibition.” Highlights of a satellite to the 15th Scientific Meeting of the International Society of Hypertension, Melbourne, Australia, March 25, 1994. Amsterdam: Scientific Communications.
Ram CVS. Secondary hypertension: workup and correction. Hospital Practice, April 15, 1994:137-150.
Ram CVS, Ames RP, Applegate WB, Burris JF, Davidov ME, Mroczek WJ. Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension. Clinical Cardiology 17:251-56, 1994.
Ram CVS, Lugo C, Fierro-Carrion GA, Brown SM, Kaplan NM, Sienko M. Renal haemodynamic effects of ACE inhibition with ramipril in essential hypertension. In: Unger T, Ball SG eds. ACE Inhibitors and High Risk Patients. Sussex, UK: Euromed Communications Ltd., 1994:51-58.

1995

Frishman WH, Ram CVS, McMahon FG, Chrysant SG, Gaff A, Kupiec JW, Hsu H. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group. J Clin Pharmacol 1995;35(11):1060-66.
Ram CVS. Alpha blockers in the treatment of hypertension. In: Sainani GS ed. Current Concepts in Hypertension. Bombay, India: Indian College of Physicians, 1995:200-209.
Ram CVS. Hypertension and other cardiac risk factors among Asian Indians. Am J Hypertension 1995;8(12 Part 2):124S-27S.
Ram CVS. Immediate management of severe hypertension. Cardiol Clinics 1995;13:579-91.
Ram CVS. Introduction to secondary forms of hypertension. Seminars in Nephrology 1995;15:71.
Ram CVS, Clagett GP, Radford LR. Renovascular hypertension. Seminars in Nephrology 1995;15:152-74.
Ram CVS, Fierro-Carrion, GA. Pheochromocytoma. Seminars in Nephrology 1995;15:126-137.
Ram CVS. Secondary forms of hypertension. In: Ram CVS ed. Seminars in Nephrology, Vol 15, March 1995.
Ram CVS. Diagnosis and management of renovascular hypertension – Current Concepts. In: Sainani GS, Talwalkar PG, Eds. Current Concepts in Hypertension. Indian college of Physicians, Association of Physicians of India, 1995:64-106.
Ram CVS. Alpha blockers in the treatment of hypertension. In: Sainani GS, Talwalkar PG, Eds. Current Concepts in Hypertension. Indian college of Physicians, Association of Physicians of India, 1995:200-209.
Ram CVS. Hypertensive crisis. In: Kaplan, NM, Ram CVS, Eds. Individualized Therapy of Hypertension, Marcel Dekker, Inc, New York; 1995: 223-244.

1996

Ram CVS. Diagnosis and management of renovascular hypertension-current concepts. In: Sainani GS ed. Current Concepts in Hypertension. Bombay, India: Indian College of Physicians, 1996:64-106.
Ram CVS. Arteriographic diagnosis of renal artery stenosis: how many views is enough? (Letter) Consultant 1996;36:205-206.
Ram CVS. Current trends and future prospects in the pharmacologic management of hypertension. Am J Managed Care 1996;II (Suppl 1): S4-S10.
Ram CVS. Hypertension: When to suspect underlying pheochromocytoma or aldosteronism. Consultant 1996;33:147-53.
Ram CVS. Hypertensive crises. In: Hurst JW ed. Medicine for the Practicing Physician, 4th edition. Stamford, CT: Appleton & Lange 1996:1086-92.

1997

Fierro-Carrion G, Ram CVS. Nonsteroidal anti-Inflammatory drugs (NSAIDs) and blood pressure. Am J of Cardiology 1997: September, Vol 80; 775-770.
Ram CVS. Renovascular hypertension. Current Opinions in Nephrology and Hypertension 1997;6:575-579.
Ram CVS. Treatment of hypertension, today and tomorrow. Published by Interactive Network for Continuing Education (and Norvartis): 1997; p 1-10.
Zubairi A, Ram CVS. Low Platelets and severe hypertension. Cortlandt Forum 1997;10 (11): 272-275.

1998

Ram CVS, Ackad T. The hypertension optimal treatment (HOT) trial: Appraisal. Seminars in Hypertension Management 1998; 1:7-10.
Ram CVS, Fierro G. The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure. Am J Therapeutic 1998; 5: 101-105.
Ram CVS. Best blood pressure is the lowest – Sparing polypharmacy. In: Expert Advice: Internal Medicine News 1998; 31 (19): 10.
Ram CVS. Study shows low blood pressure reduces heart attack-rates. Southwestern Times 1998; August: 1-2.
Ram CVS, Zubairi A. A possible surgical complication. Courtlant Forum 1998 Dec;11(12): 254-255.

1999

Ram CVS. Renovascular hypertension: Evolving diagnostic techniques (Perspective). ACC Current Journal Review 1999; Jan/Feb 8:23-27.
Ram CVS. Direct vasodilators. In: Izzo JL, Black HR eds. Hypertension Primer 2nd Edition, The essentials of high blood pressure. American Heart Association, Dallas, Texas, Chapter 133. 1999: 385-387.
Ram CVS. The hypertension optimal treatment trial: A precursor for lowering the target blood pressure level. Current Hypertension Reports 1999, 3:195-1996.
Bohan JS, Kaplan NM, Ram CVS. Hypertensive crises: Treat the patient, not the BP. Patient Care 1999;33(3):129-150.
Ram CVS. Systemic Hypertension. In: Sainani GS ed. API Textbook of Medicine, Sixth Edition, Association of Physicians of India, Bombay 1999; Cardiology Section, Chapter 21, 403-410.
Ram CVS. Secondary Hypertension. In: Sainani GS ed. API Textbook of Medicine, Sixth Edition, Association of Physicians of India, Bombay 1999; Cardiology Section, Chapter 21, 410-414.
Ram CVS, Vergne-Marini P. Role of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease. Current Hypertension Reports 1999; 1:431-435.
Fenves AZ, Ram CVS. Fibromuscular dysplasia of the renal arteries. Current Hypertension Reports 1999; 1(6):546-549.
Ram CVS. Forward. In: Anand MP, Billimoria AR, eds. Hypertension: An international Momograph 2000. IJCP Group of Publications, India, 1999.
Ram CVS. Guidelines for the work-up of secondary forms of hypertension. In: Anand MP, Billimoria AR, eds. Hypertension: An international Momograph 2000. IJCP Group of Publications, India, 1999: 77-78.
Ram CVS. Renovascular hypertension: Emerging non-invasive diagnostic techniques. In: Anand MP, Billimoria AR, eds. Hypertension: An international Momograph 2000. IJCP Group of Publications, India, 1999: 79-86.
Ram CVS. Refractory hypertension. In: Anand MP, Billimoria AR, eds. Hypertension: An international Momograph 2000. IJCP Group of Publications, India, 1999: 291-296.

2000

Tumlin JA, Dunbar LM, Oparil S, Buckalew V, Ram CVS, Mathur V, Ellis D, McGuire D, Fellmann J, Luther RR. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multi-center randomized trial: Fenoldopam Study Group. Acad Emerg Med 2000 Jun; 7(6):653-62.
Ram CVS. Endothelial function and dysfunction in cardiovascular disease. J of Clin Hypertension 2000 July/Aug;2:267-272.
Ram CVS. Early ACE inhibitor treatment may slow progression of renal disease. Cardiology Review 2000 May; 17(5) Suppl:4-6.
Kaplan N, Ram CVS. Changing approaches to diagnosis and treatment of hypertension. In: Oparil S, Weber MA, eds. Hypertension: A Companion to Brenner and Rector’s The Kidney. W.B. Saunders Company, 2000.

2001

Vergne-Marini P, Nesser D, Toto R, Hewerdine J, Ram CVS. Short-term stability of blood cyclosporine level and renal function after conversion from neoral capsules to Eon brand cyclosporine in renal transplant patients. J Am Soc Nephrol 2001;12:921A.
Ram CVS. Hypertension in pregnancy. Perspectives in Cardiology 2001 Aug; 17:51-52. Deedwania PC, Pitt B, Ram CVS. What is the role of angiotensin II receptor blockers? Patient Care 2001 Nov; 35(22): 40-45.
Ram CVS. Using angiotensin receptor blockers: One on one with C. Venkata S. Ram, MD. Patient Care 2001 Nov; 35(22): Online only pg 2.
Ram CVS. Refractory hypertension. In: Weber MA, ed. Hypertension Medicine. Humana Press, Totowa New Jersey, 2001.
Ram, C.V.S. Actions of Angiotension Receptor Blockers: Pharmacological and clinical relevance in cardiovascular risk management. Medicus International 2001;October:1-2.

2002

Ram CVS, Vergne-Marini P, Villemarette L, Hatfield E. Effects of angiotensin receptor blockade (ARB) on glomerular filtration rate (GFR) and on postural blood pressure (BP). Am J Hypertension April 2002: 15(4) Part II;170A.
Ram CVS, Toto R, Nesser D, Harris L, Lemons P, Hatifeld E. Fate of Hypertension (HTN) before and after kidney transplantation in patients with end stage renal disease (ESRD). Am J Hypertension April 2002; 15(4) Part II; 172A.
Fenves AZ, Ram CVS. Are angiotensin converting enzyme inhibitors and angiotensin receptor blockers becoming the treatment of choice in African-Americans? Current Hypertension Reports 2002; 4:286-289.
Ram CVS, Fenves AZ. Clinical pharmacology of antihypertensive drugs. Cardiol Clin 2002;20:265-280.
Ram CVS. Antihypertensive drugs: An overview. Am J Cardiovasc Drugs 2002;2(2):77-89.
Bakris G, Sica D, Ram CVS, Fagan T, Vaitkus PT, Anders RJ. A comparative trail of controlled-onset, extended-release Verapamil, Enalapril, and Losartan on blood pressure and heart rate changes. Am J Hypertension 2002;15:53-57.
Ram CVS. Cardiorenal benefits of angiotensin receptor blockade. In: Saunders E, Yancy CW, eds. Cardiovascular Summit Highlights. Association of Black Cardiologists, Inc. 2002:14-15.
Ram CVS. Usefulness of Lercanidipine, a new calcium antagonist, for systemic hypertension. Am J Cardiol 2002 Jan;89(2):214-215.
Ram CVS, Fenves AZ. Refractory hypertension. Current Concepts in Hypertension 2002 Apr;4(4):3-6.
Ram CVS. The newer calcium antagonists: Implications for the practicing clinician. Resident & Staff Physician 2002; 48: 16-24.
Ram CVS. Endothelin antagonists. Am J of Therapeutics; In press, 2002.
Kumar S, Ram CVS. Classification and diagnosis of hypertension. In: Luscher TF, Ed. International Handbook of Cardiovascular Risk: Prevention and Management. Euromed Communications Ltd, Anthony Cedex, France. 2002; Chapter 3: 35-45.

2003

Ram CVS. Getting to goal in complex patients. Clinical Cardiology; Vol 26 (Suppl II) 2003
Ram CVS, Fenves A. Direct Vasodilators. The Essentials of High Blood Pressure (Editors, Izzo J. and Black, M)I; American Heart Association, 2003; Chapter C147: 437-439.
Tuncel M, Ram CVS. Hypertensive emergencies: Etiology and management. Am J Cardiovasc Drugs, 2003; 3(1): 21-31.
Ram CVS. Renal protection and antihypertensive drugs. Cardiology Special Edition, 2003; 9: 27-30.
Ram CVS. Management of refractory hypertension. Am J of Therapeutics 2003; 10: 122-126. Bakris G, Ram CVS. Recent BP trials and JNC 7: What they mean in practice. Patient Care 2003; 37: 17-26.
Ram CVS. Possible Therapeutic role of endothelin antagonists in cardiovascular disease. Am Journal of Therapeutics 2003; 10: 396-400.
Germain M, Ram CVS, Ghaduri S, Tang KL, Lausner M, Curzi M. Retrospective review of extended epoetin alfa dosing in patients with anemia of chronic kidney disease (CKD): Final Results of the RAPID Study. (Submitted for publication).
Ram CVS, Vergne-Marini P. Management of transplant hypertension. In: Egan BM, Basil JN, Lackland DT, Eds. Hot Topics: Hypertension. Hanley & Belfus, Philadelphia, Pennsylvania. 2003; 335-344.

2004

Toto R, Rinner S, Ram CVS. Ace inhibitors and Target organ protection: An expanded role for these antihypertensive agents? Postgraduate Medicine 2004; 116 (2): 11-22.
Silverstein R, Fenves A, Ram CVS. ARBs and Target organ protection: Exploring benefits beyond their antihypertensive effects. Postgraduate Medicine 2004; 116 (2): 31-41.
Ram CVS, Vergne P. Arresting cardiovascular disease progression. Postgraduate Medicine 2004; 116 (2): 45-48.
Ram CVS. Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: A review of the factorial design studies. J of Clin Hypertension 2004; 6 (10): 569-577.
Ram CVS. Editor for hypertension. In Current Cardiology Reports 2004; 6 (6): 401-433.
Ram CVS. Understanding refractory hypertension. Patient Care 2004; 38: 12-16.
Ram, CVS, Vergne-Marini, P. “Hypertension: Hot topics: Chapter 32: Management of transplant hypertension, pp 335-343. Brent M. Egan, MD, Jan N. Basile, MD, Daniel T. Lackland, DrPH. 2004 by Hanley & Belfus, Inc.

2005

Ram CVS. Hypertensive urgencies and emergencies: Considerations for treatment. In: Weir MR, Ed. Hypertension. American College of Physicians, Philadelphia. 2005; 203-220.
Ram CVS. From Guidelines to practice: Practical considerations of hypertension management. Adv Stud Med. 2005; 5(6B): S543-S549).
Ram CVS. Angiotension receptor blockage in cardiovascular medicine: New considerations for the clinical cardiologist CME monograph. University of Texas Southwestern Medical Center, Dallas, TX, September 1, 2004 to July 31, 2005.
Ram CVS. Current understanding of the angiotension receptor’s unique role in hypertension, pulse and pressure. March 2006, Nenograph by Medcom Interantional for Sovay Pharma, Manila, Philippines.
Silverstein R, Ram CVS. Angiotensin-receptor blockers: Benefits beyond lowering blood pressure. Cleveland Clinic Journal of Medicine 2005; 72: 825-832.
Ram CVS: (Editor): Hypertension / Current Cardiology Reports. 2005; 7: 405-440.
Barri Y, Palmer B, Ram CVS. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function. The latest concepts in pathology and pharmacologic treatment. Postgraduate Medicine (Special Report). December 2005; p.34-45.
Ram CVS. Cardiovascular-renal disorders and the therapeutic impact of adrenergic blockade. Postgraduate Medicine (Special Report). December 2005; p.4-5.
Ram CVS: (Editor): ß-Blockers and cardiovascular disease. Postgraduate Medicine (Special Report). December 2005.
Ram CVS, Velez RL: (Editors): Treatment of hypertension Vol.25. Seminars in Nephrology. July 2005; p 189-280.
Ram CVS, Velez RL. Kidney and blood pressure: Partners in health and disease. Seminars in Nephrology. 2005; 25: 189-190.
Fenvez A, Ram CVS. Drug treatment of hypertensive urgencies and emergencies. Semin Nephrol 25. 2005; 272-280.
Wiederkehr M, Toto R, Fenves A, Ram CVS. Hypertension and the kidney. Semin Nephrol 25. 2005; 236-245.
Senitko M, Fenves AZ, Ram CVS. An update on renovascular hypertension. Current Cardiology Reports 2005 Nov; 7(6):405-11.
Ram, CVS. Does the clinical and therapeutic profile of eprosartan contribute to end organ protection? J Clin Basic Cardiol 2005; 8: 7.

2006

2007

De La Sierra, A, Ram, CVS. Introduction: The pharmacological profile of eprosartan – implications for cerebrovascular and cardiovascular risk reduction. Current Medical Research and Opinion, Vol 23, Suppl. 5, 2007, S1-93.
Ram, CVS. Angiotensin blockade with eprosartan: vascular and functional implications. Current Medical Research and Opinion, Vol. 23, Suppl. 5, 2007, S5-S11.
Ram CVS, Giles T. Need to revisit step therapy for angiotensin receptor blockers. J Managed Care Pharmacy. 2007; 13:528-529.
Ram CVS. Direct renin inhibitors: new approach to anti-hypertensive drug treatment. J Clinical Hypertension 2007; 9 (8): 615-621.
Ram CVS, Rudmann MA. Unique dual mechanism of action of eprosartan: effects on systolic blood pressure, pulse pressure, risk of stoke and cognitive decline. Expert Rev. Cardiovasc. Ther. 5(6), 1003-1011 (2007).

2008

Ram CVS, Fenves A. Direct arterial dilators. In hypertension primer. American Heart Association, Dallas, 2008. Pages 469-471.
Ram CVS. Angiotensin receptor blockers: Current status and future. American J. Medicine, In Press.
Ram CVS. New and investigational therapies offer promise in treating heart disease with diastolic dysfunction. Cardiology Review, 2008;25(6):10.
Ram CVS. β-Blockers in hypertension: Truths and half-truths. The Journal of Clinical Hypertension, 2008; 10:516-519.
Ram CVS. Risk of new-onset diabetes mellitus in patients with hypertension treated with beta blockers. Am J Cardiol 2008: 102:242-244.
Ram CVS. New and investigational therapies offer promise in treating heart disease with diastolic dysfunction. Cardiology Review (cardiovascular chronicles) June 2008: 10.
Messerli FH, Bangalore S, Ram CVS. Telmisartan, ramipril, or both in patients at high risk of vascular events. N Engl J Med 2008; 359:426-427.
Ram CVS. Angiotensin receptor blockers: current status and future prospects. Am J Med. 2008, 121:656-63.
Ram CVS in Beta-Blockers and Hypertension in 2008 a Monograph. American Society of Hypertension and the France Foundation, Old Lyme, Connecticut. 2008 Aug 08: pages 1-28.
Vidt DG, Ram CVS, (Section Editors). Antihypertensive therapy: Patient selection and special problems. Current Hypertension Reports 2008; 10:337-381.
Silverstein RL, Ram CVS. Resistant hypertension. Prim Care Clin Office Pract 2008. 35:501-513.
Ram, CVS. ONTARGET Study of telmisartan, ramipril, or both in high-risk patients. Current Hypertension Report. 2008;10:345-348.
Ram, CVS, Deedwania, PC. Angiotensin receptor blockers and cardiovascular protection: Are we ONTARGET? American Journal of Cardiology 2008;102:1282-1283.

2009

Ram, CVS. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: A review of factorial-design studies. Current Medical Research and Opinion 2009; 25:177-185.
Ram, CVS. Direct inhibition of renin: A physiological approach to treat hypertension and cardiovascular disease. Future Cardiol. 2009;5:453-465.
Ram, CVS, Silverstein, RL. Treatment of hypertensive urgencies and emergencies. Current Hypertension Reports 2009;11(5):307-314.
Ram, CVS, Fenves, AZ. Management of hypertension in hemodialysis patients. Current Hypertension Reports. 2009;11(4):292-298.

2010

Ram CVS. Could baroreceptor activation therapy be the future for treating hypertension and other chronic cardiovascular conditions? J Clin Hypertens 2010;12(4):288-291.
Ram CVS. Central aortic blood pressure: Emerging clinical value. In Medicine Update 2010 (volume 20), Editor, Rao MS. Published by Association of Physicians from India. Pages 396-399.
Ram CVS. Baroreceptor activation therapy for treating resistant hypertension: A status report. In Medicine Update 2010 (volume 20), Editor Rao, MS. Published by Association of Physicians from India. Pages 404-406.
Ram CVS. Central aortic blood pressure assessment and cardiovascular risk. Indian Heart J. 2010;62:13-16.
Ram CVS, Giles TD. The evolving definition of systemic arterial hypertension. Curr Atheroscler Rep 2010, May ;12(3):155-8.
Ram CVS. Emerging importance of central aortic blood pressure as a prognostic marker. Cardiovascular Risk Abstracts, 2010;18:2-5.
Ram CVS. Optimal regimen-based pharmacotherapy of hypertension in patients with concomitant conditions. In Evidence-based management of hypertension. (Editor Weir MR). tfm Publishing Limited, Shrewsbury, UK, 2010, pages 53-67.
Friedewald VE, Ram CVS, Wesson DE, etal. The Editor’s Roundtable: Effect of nonsteroidal anti-inflammatory drugs on blood pressure. Am J Cardiol 2010;105(12):1759-1767.
Friedewald VE, Ganz P, Kremer JM, Mease PJ, O’Dell JR, Pearson TA, Ram CVS. AJC Editor’s Consensus: Rheumatoid arthritis and atherosclerotic cardiovascular disease. Am J Cardiol 2010;106(3):442-447.
Ram CVS. Hypertension Trials 2008: Clinical Implications. Indian Heart J. 2010;62:451-453.
Friedewald VE, Nesbitt SD, Ram CVS, Roberts WC. The Editor’s Roundtable: Hypertension in African Americans and Other Non-Caucasian Ethnic Groups. Am J Cardiol 2010;106(10):1466-1472.
Ram CVS. Beta-blockers in Hypertension. Am J Cardiol. 2010 Dec 15;106:1819-25.

2011

Ram CVS. Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide Triple Combination for Hypertension. Expert Rev Cardiovasc Ther. 2011 Jan;9:9-19.
Ram CVS, Sachson R, Littlejohn T, etal. Management of hypertension in patients with diabetes using an Amlodipine, Olmesartan Medoxomil, and Hydrochlorothiazide-based titration regimen. Am J Cardiol 2011;107:1346-1352.
Ram CVS. Reappraisal of role of angiotensin receptor blockers in cardiovascular protection. Vascular Health and Risk Management 2011:7;315-319.
Ram CVS. An encapsulated historical perspective of hypertension. Cardiovascular Risk Abstracts, Summer 2011, Euromed Communications, page 2-8.
Ram CVS, Lerma EV. Refractory hypertension in nephrology secrets. (Editors, Lerma EV and Nissenson AR). Elsevier Mosby Publishers, Philadelphia 2011;485-491.
Ram CVS, Lerma EV. Pharmacological Treatment of Hypertension. (Editors, Lerma EV and Nissenson AR). Elsevier Mosby Publishers, Philadelphia 2011;499-506.
Ram CVS. Emerging Importance of Central Aortic Blood Pressure as a Prognostic Marker. Journal of Applied Therapeutic Research 2011;8(2):59-64.
Elliott WJ, Ram CVS. Calcium Channel Blockers. American Society of Hypertension Special Issue Paper, Review Paper. Journal of Clinical Hypertension 2011;13(9):687-689.
Ram CVS, Silverstein RL. Refractory “Resistant Hypertension”: New Terminology for an Old Problem. In Press. J Clin Hypertension. 2012.
Ram CVS, Ramaswamy K, Qian C, Biskupiak J, Ryan A, Quah R, Russo PA. Blood pressure outcomes in patients receiving angiotensin II receptor blockers in primary care: A comparative effectiveness analysis from electronic medical record data. J Clin Hypertension 2011;13:801-12.
Ram CVS. Diabetes and Hypertension: New Dimensions in Patho-Physiology and Therapeutics. Indian Heart Journal, 2011; 63:5A 7-11.

2012

Ram CVS, Silverstein RL. “Refractory” Resistant Hypertension: New Terminology for an Old Problem. J Clinical Hypertension 2012;14:5-6.
Siddharth KM, Kapur S, Ram CVS. Angiotensin Converting Enzyme Gene Polymorphism and Hypertension: No Ace Yet in the Pack of Cards. Journal of Association of Physicians from India. 2012;60:9-10.
Ram CVS, Farmer JA. Metabolic Syndrome in South Asians. J Clinical Hypertension 2012;14:561-565.
Ram CVS. Metabolic Syndrome in South Asians. Emerging Frontiers of Medicine 2012:15-30., editor Manoria PC, published by Manoria PC, Bhopal, India.
Ram CVS, Vasey J, Panjabi S, Qian C, Quah R. Comparative Effectiveness Analysis of Amlodipine/Renin-Angiotensin System Blocker Combinations. J Clinical Hypertension 2012;14:601-610.
Ram CVS, Vasey J, Panjabi S, et al. Comparative effectiveness of renin angiotensin system blocker/amlodipine combinations. J Clinical Hypertension 2012; 14( supplement 1):A 65
Ram CVS, Sachson RA, Shojaee A, et al. Efficacy of an amlodipine/olmesartan medoxomil based regimen in type 2 diabetics with stage 1 or 2 hypertension. J Clinical Hypertension 2012; 14 ( supplement 1): A 67
Ram CVS, Hypertension in Pregnancy. Annals of Indian Medical Association, Academy of Medical Specialities 2012; Pages 33-39.

2013

Ram CVS, Metabolic Syndrome and Subclinical cardiovascular disease. In Cardiovascular Risk and Metabolic Syndrome (Rao MS, editor) published by Indian College of Physicians and Association of Physicians from Mumbai, India, 2013; Pages 25-33.
Ram CVS, Wali M. Neurohormonal and cytokine activation in heart failure. In Monograph on Heart Failure (Editor, Banerjee AK). Association of Physicians from India; Mumbai, India. 2013; Pages 22-31.
Ram CVS, Editor, Prevention of Hypertension issue. J of Preventive Cardiology 2012; 2:347-388.
Ram CVS, Wali M. Primary Prevention of Hypertension. J of Preventive Cardiology 2013; 2:347-349.
Ram CVS, Wali M. Renal denervation in resistant hypertension: An emerging novel therapy.Journal of Clinical and Preventive Cardiology. 2013;2:73-83
Ram CVS, Naik SR. Latest (2013) European Guidelines for Hypertension: A commentary. J of Indian College of Cardiology, 2013;3:157-158
Uddaraju A, Ram CVS. Hypertension in children, not a “small” problem. Indian Heart Journal. 2013;65:501-503.
Ram CVS. Fixed-dose triple-combination treatments in the management of hypertension. Managed Care. 2013;22:45-55.
Ram CVS. Does hypertension cause atherosclerosis? In HYPERTENSION AND CLINICAL CARDIOLOGY (Editor, Ram CVS), Euromed publications, Hamshire, U.K, 2013, P: 17-26.
Ram CVS. Chronic kidney disease: A high risk population for cardiovascular disease. In HYPERTENSION AND CLINICAL CARDIOLOGY (Editor, Ram CVS), Euromed publications, Hamshire, U.K, 2013, P: 69-78.

2014

Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend R, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB. Clinical practice guidelines for the management of hypertension in the community a statement by the American society of hypertension and the International society of hypertension. J Hypertens. 2014;32:3-15.
Ram CVS, Kumari A. Impact of anti-hypertensive therapy on cardiovascular disease burden in Asia: Renewed hope with immense scope. Journal of the American Society of Hypertension. 2014;8:142-143.
Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend RR, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB. Clinical practice guidelines for the management of hypertension in the community a statement by the American society of hypertension and the International society of hypertension. J Clin Hypertension. 2014;16:14-26.
Ram CVS, Kumar AS. Renal denervation therapy for resistant hypertension: a clinical update. J Human Hypertension 2014; 1-6.
Ram CVS and the HALT investigators. Feasibility of a real-world protocol to identify individuals at high risk for myocardial infarction: The HALT Heart Attack in Our Lifetime (HALT) Study. J of Indian College of Cardiology 2014;4:63-66.
Ram CVS. Hypertension Guidelines in Need of Guidance. Journal of Clinical Hypertension. 2014, March 26th
Ram CVS. Selected highlights from American Society of Hypertension 2013. In Hypertension and Cardiovascular Disease: Current and Emerging Concepts (editor, Ram CVS), Pages 121-129, Euromed Communications, passfield, U.K. 2014.
Ram CVS. Chirally pure drugs for hypertension treatment. In Medicine update (Association of Physicians of India) (Editor Joshi SR). 2014;241:933-939.
Ram CVS. 2013 European guidelines for hypertension: Clinical implications. In postgraduate Medicine, Indian College of Physicians (Editor Gupta SB). 2014;18:125-128.
Ram CVS. Various guidelines for hypertension: A reasoned commentary. Cardiology Today 2014; 17 (July-August): 167-170.
Wali M, Sharma S, Ram CVS. Resistant Hypertension: Clinical evaluation and management. In Cardiology update (Editor, Chopra HK), Cardiological Society of India, Jaypee Publishers, New Delhi. 2014: Pages 622-628.
Ram CVS: Central aortic blood pressure as a prognostic marker in hypertension. In Cardiology update (Editor, Chopra HK), Cardiological Society of India, Jaypee Publishers, New Delhi. 2014: Pages 661-668.

2015

Ram CVS. Hypertension guidelines: Good-bye to confusion and Welcome to clarity. Indian Heart Journal 2015;67:18-22.
Ram CVS. The burden of hypertension and cardiovascular disease in India. European Heart Journal 2015;36:702-707.
Wali M, Sharma S, Ram CVS. Resistant Hypertension: Clinical evaluation and management. In Cardiology update 2014 (Cardiological Society of India) pages 622-628, 2015, Jaypee Brothers Medical Publishers, New Delhi, India.
Ram CVS. Central Aortic Blood Pressure as a Prognostic Marker in hypertension. In Cardiology update 2014 (Cardiological Society of India) pages 661-668, 2015, Jaypee Brothers Medical Publishers, New Delhi, India.
Wali M, Naik SR, Ram CVS. Resistant hypertension in patients with chronic kidney disease. In Chronic Kidney Disease And Hypertension (Editors Weir MR and Lerma EV). Springer Science and Humana press, New York, USA, 2015.
Ram CVS, Kumar AS. Physiological Rationale for Renal Denervation Therapy in Hypertension. In Renal Denervation: A New Approach to Treatment of Resistant Hypertension (Editor Heuser RR), Springer-Verlag, London, 2015 (P 9-13).
Wali M, Ram CVS. Metabolic Syndrome in South Asians. In Metabolic Syndrome: A Comprehensive Textbook, Springer, New York, in press.
Nair T, Wali M, Ram CVS. 24 hour ABPM in clinical practice. Indian context. In Emerging concepts, emerging technologies, emerging therapies (Editors, Manoria PC, Manoria P, Manoria P), Pages 27-37, 2015, publisher, Manoria, Bhopal, India.
Pothineni NVK, Ram CVS. Hypertension management in STEMI. In STEMI UPDATE (Chopra HK Editor), Jaypee Medical Publishers, New Delhi, India, 2015. Pages 825-829.

2016

Ram CVS. Hypertensive disorders in pregnancy: Newer mechanisms. In progress in Medicine 2016 – Medicine update 2016, Chapter 317, pages 1649-1652 (Editors, Pareek KK, Wander GS). Jaypee Medical Publishers 2016, New Delhi.
Ram CVS. Hypertension guidelines: From confusion to clarity. Thanks to SPRINT. In Medicine update 2016 – progress in Medicine 2016, Chapter 363, (Editors, Wander GS, Pareek KK), Jaypee Medical Publishers 2016, New Delhi. Pages 1895-1898.
Bharadiya AA, Ram CVS. Rationale and Importance of Combination Drug Therapy in Hypertension. In Medicine update 2016 – progress in Medicine 2016, Chapter 364, (Editors, Wander GS, Pareek KK), Jaypee Medical Publishers 2016, New Delhi. Pages 1899-1904.
Ram CVS, Bharadiya A. Resistant Hypertension: Management issues. In Cardiology Update 2015 / Cardiological Society of India (Guha S, editor) chapter 18, pages 108-115, Jaypee Medical Publishers, New Delhi; India, 2015.
Ram CVS. The burden of cardiovascular disease in India. European Heart Journal 2015;36:702-707.
Lackland DT, Ram CVS. World Hypertension League: Its Scope, Purpose, and Impact in South Asia. Hypertens J 2016;2(2):55-56.

2017

Ram CVS, Khan AM, Wali M. Hypertension, Atrial Fibrillation and Other Cardiac Arrhythmias. In Atrial Fibrillation Update. A Textbook of Cardiology (Editors, Chopra HK, Wander GS, Chandra P, and Kumar V). Jaypee Medical Publishers, New Delhi 2017. Chapter 17, Pages 75-82.
Ram CVS. Renal Denervation Therapy for Resistant Hypertension: Possible pathophysiological reasons. In Cardiology Update 2016 (Editors, Hiremath MS, Deshpande NV). Jaypee Medical Publishers, New Delhi 2017. Chapter 8, Pages 45-50.
Ram CVS, Wali M. Device-based Therapies for Resistant Hypertension: A Status Update. In Cardiology Update 2016 (Editors, Hiremath MS, Deshpande NV). Jaypee Medical Publishers, New Delhi 2017. Chapter 9, Pages 51-57.
Singh M, Kotwal A, Mittal C, Babu SR, Bharti S, and Ram CVS. Prevalence and correlates of hypertension in a semi-rural population of Southern India. J Hum Hypertens. 2017, Nov 27. doi:10.1038/s41371-017-0010-5. [Epub ahead of print].
Wali M, Ram CVS. Metabolic effects of anti-hypertensive drugs. In Cardio diabetes Update (Chopra HK, et al editors), Jaypee Brothers, New Delhi 2017, pages 358-361.
Ram CVS. Blood Pressure Goals for the Treatment of Hypertension in patients with Cardiovascular Disease. In Cardiology Update (Cardiological Society of India), Editors, Chandra KS, Bansal M. Elsevier, 2017. Chapter 7, pages 55-60.

2018

Wander GS, Ram CVS. Global Impact of 2017 American Heart Association / American College of Cardiology, Hypertension Guidelines. A Perspective From India. Circulation 2018;137:549-550.
Ram CVS. Latest guidelines for hypertension: Adopt and Adapt. J American Society of Hypertension. 2018;12:67-68.
Lackland DT, Beilin LJ, Campbell RC, Jaffe MG, Orias M, Ram CVS, Weber MA, Zhang XH. Global implications of blood pressure thresholds and targets: Guideline conversations from the World Hypertension League. Hypertension 2018;71:985-987.
Ram CVS. In Memoriam. Thomas D.Giles (February 24, 1938-April 17, 2018). J of American Society of Hypertension. 2018;12:484-485.
Byrd JB, Ram CVS, Lerma EV. Pharmacologic treatment of hypertension (chapter). In Nephrology Secrets, Edited by Lerma EV, Sparks MA,, and Topf JM, Elsevier, Philadelphia. Chapter 69, Pages 477-482.
Ram CVS, Abhyankar MV. Hypertension in India 2018: Clinical and Therapeutic Issues. In CSI TEXTBOOK OF CARDIOLOGY: The Indian Perspective. Editor-in-Chief DEB PK. JayPee Medical Publishers, New Delhi, India, 2018. Chapter 48, pages 651-659.
Wander GS, Ram CVS. Blood Pressure – Methods to record & numbers that are significant: Lets make a tailored suit to suit us. Indian J Med Res 2018;147:435-438.
Wander GS, Ram CVS. Optimal Blood Pressure Goals recommended by the Latest Hypertension Guidelines. India may benefit the most. European Heart J. 2018;33:3016-3017. Ram CVS. European and American Hypertension Guidelines and Goal Blood Pressure: Relevance to India. Indian Heart J. 2018;70:465-468
Gupta R, Gaur K, Ram CVS. Emerging Trends in Hypertension Epidemiology in India. J Human Hypertension. 2018; 25 September.
Wali M, Ram CVS. Mechanisms of vascular disease in diabetes. In INTERNATIONAL Textbook of Diabetes (Editors Sadikot, Tripathi K, Saboo B). Jaypee Brothers Medical Publishers, New Delhi, INDIA. 2018; Chapter 31, pages 204-207.
Ram CVS. Initial choice of drugs in uncomplicated hypertension: Not monotherapy anymore but combination. In Cardiology Update 2018, Cardiological Society of India (Goswami KC, editor-in-chief). Chapter 20, pages 123-128. Jaypee Brothers Medical Publishers, New Delhi, India, 2018.

2019

Ram CVS; “Recent Guidelines for Hypertension: A Clarion Call for Blood Pressure Control in India. Circulation Research/AHA, 2019, in press”.
Ram CVS. Status of renal denervation therapy for hypertension: Still in search of the magic bullet. Circulation 2019;139:601-603.
Ram CVS. Systemic hypertension. In Tandon’s Textbook of Cardiology (Editors- Prabhakaran D, Kumar RK, Naik N, Kaul U), Wolters-Kluwer, New Delhi, India, 2019. Chapter 34, pages 912-928.
Chopra HK, Ram CVS. Recent Guidelines for Hypertension: A Clarion Call for Blood Pressure control in India”. Circulation Research, 2019;124:984-986.
Gupta R, Ram CVS. Hypertension epidemiology in India: Emerging aspects. Current opinion in Cardiology 2019;34:331-341.
Mittal, C*, Singh M, Bakhshi T, Babu SR, Rajagopal S, Ram CVS. Isolated diastolic hypertension and its risk factors in semi-rural population of South India., Indian Heart Journal, https://doi.org/10.1016/j.ihj.2019.07.00.
Srinivas V, Soma Sekhar M, Ram CVS. Cardiovascular Disease in patients with Chronic Kidney Disease: An Overview. In Coronary and Diabetes (CAD) Update, 2019. (Editors Dalal J, Deshpande NV, and Mardikar HM). Pages 101-116. Published by Clinate, Nagpur, India on behalf of Cardiovascular Society of India.
Wali M, Ram CVS. Combination Therapy, not Monotherapy is the solution for Blood Pressure control: A Guideline based approach. In Cardiology Update 2019. Cardiological Society of India, pages 217-227. Evangel Publications, New Delhi, 2019 (Editor- M K Das).
Indrani T, Naik SR, Ram CVS. Cardiovascular Disease in Women: A Clinical Overview. In Cardiology Update 2019. Cardiological Society of India, pages 141-152. Evangel Publications, New Delhi, 2019 (Editor - M K Das).
Pareek A, Chopra HK, and Ram CVS. Chlorthalidone: A diuretic of first choice in hypertension and heart failure. In Advances and Innovations in Heart Failure (Editors – Chopra HK, Nanda NC, Narula J), Pages 135-140, Jaypee Brothers Medical Publishers, New Delhi, 2019.
Yang E, Sharma G, Ram CVS. American and European Hypertension Guidelines: Finding common ground. American Journal of Cardiology 2019;123:1378-1382.
Ram CVS, Reddy KS. Clinical recognition and management of hypertensive emergencies. In Emergencies in Medicine (Editor - Nadagouda VG), pages 121-130. Association of Physicians from India, Mumbai 2020.

2020

Whelton PK, Campbell NRC, Lackland DT, Parati G, Ram CVS, Weber MA, Zhang XU. Strategies for prevention of Cardiovascular disease in adults with hypertension. J Clinical Hypertension 2020;22:132-134.
Ram CVS. The triad of orthostatic hypotension, blood pressure variability: a new syndrome? J of Hypertension 2020;38:1031-1032.
Ram CVS. In Memoriam: Dr.Norman M. Kaplan (1931-2020). J of Hypertension 2020;38:1391-1391.
Chopra H, Kasliwal RR, Muruganathan A, Wali M, Ram CV. COVID-19, hypertension, and cardiovascular disease. J Diabetol, 2020;11:57-64.
Ram CVS, Babu GR, Prabhakaran D, Covid-19 Pandemic in India – Is the curve now flat? European Heart Journal 2020; June 15, doi.10.1093.
Townsend RR, Dipette D, Cuff F, Weinberger MW, Ram CVS. In Memoriam: Norman M. Kaplan, January 2, 1931-April 5, 2020. Hypertension 2020;76:291-293.
Pareek A, Ram CVS, Joshi S, Mehta RT. 2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidence. J Hypertens. 2020 Nov;38(11):2335-2336. doi: 10.1097/HJH.0000000000002601.
Pareek A, Ram CVS, Agarwala R, Mehta RT. Indian guidelines on hypertension-IV (2019): need to differentiate thiazide-like diuretics. J Hum Hypertens. 2020 Sep 1. doi: 10.1038/s41371-020-00412-4. Epub ahead of print.
Pareek A, Ram CVS, Mehta RT, Dharmadhikari S. Optimising TRIUMPH with 6•25 mg chlorthalidone. Lancet Glob Health. 2020 Feb;8(2):e175.
Ram CVS. In Memoriam; Dr.Norman M. Kaplan (1931-2020): A giant in the field of hypertension has departed. European Heart Journal 2020;00, 1-2, doi 10.1093/EURHEARTJ/ ehaa 469.
McCullough PA, Alexander PE, Armstrong R...........Ram CVS......, et al. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Reviews in Cardiovascular Medicine, published online: December 30, 2020.
Ram CVS. Renal denervation therapy for hypertension: Where does it stand (or sit) at present? In Cardiology Update 2020 / Cardiological Society of India (Editors, Mohanan PP, Krishnan MN). Pages 105-112. Evangel Publishers, New Delhi, India, 2020.
Chopra HK, Kasliwal RR, Murugunathan A, Wali M, Ram CVS. COVID-19, Hypertension, and Cardiovascular Disease. Journal of Diabetology 2020;11:57-64.
Ram CVS, Wali M. Clinical Significant of Nocturnal Hypertension. A Commentary. In CAD UPDATE 2020 (Editors Dalal J, Deshpande N and Mardikar H), Pages 7-13, Clinate Publishers, CAD, Nagpur, India, 2020.
Nair T, Iyengar SS, Wander GS, Kumar AS, Ram CVS. Interaction between Hypertension, RAAS Blockade, and COVID-19: A View Point. In Hypertension Reviews 2020 (Ram CVS, Editor-in-chief), Pages 230-237, Published by Cardiological Society of India, Kolkata, India. Incessant Nature Science Publishers, Noida, India, 2020.
Arumugam G, Nagarathna R, Majumdar V, Singh M, Rambabu S, Sanjival R, Ram CVS, Nagendra HR. Yoga-based lifestyle treatment and composite treatment goals in Type 2 Diabetes in a rural South Indian setup: a retrospective study. Scientific Reports / nature research 2020- April 14;10:6402 doi 10.1038/s41598-020-631331-1.

2021

Iyengar SS, Ram CVS. Concentric Vs Eccentric Left Ventricular Hypertrophy: Does It Matter? It Is All “Blood Pressure Centered”. American Journal of Hypertension. 2021;34:581-582.
Nair T, Ram CVS. Normotensive aging: finally, an “iron in fire”. Journal of Hypertension. 2021;39:1102-1103.
Raghuram N, Ram V, Majumdar V, et al. Effectiveness of a Yoga-Based Lifestyle Protocol (YLP) in Preventing Diabetes in High-Risk Indian Cohort: A multi-center cluster Randomized Clinical Trial (NMB-TRIAL). Frontiers in Endocrinology 2021; June 11;12:664657. doi 10.3389.
Wali M, Ram CVS. Endothelial function and cardiovascular health. Hypertension Journal 2021;7:7-13.
Ram CVS. Normal blood pressure is no longer a haven --- take shelter under optimal blood pressure. JHH in Press.
Ram CVS, Kumar S, Renjen PN, et al. Risk factors predisposing to acute stroke in India: a prospective study. Journal of Hypertension 2021;39:2183-2189.
Ram CVS, Dani S, Oomman A, et al. Correlation between ambulatory blood pressure monitoring and office blood pressure measurement in patients with hypertension. A community study. Am J of Medical Sciences 2021, in press.
Ram CVS, Luscher TF, Amstein R. Cardiology Update India 2021: A growing Indo-European Educational platform to fight cardiovascular disease. European Heart Journal, in Press.
Ram CVS, Dalal J, Kahali D, et al. Management of AHA/ACC defined stage-2 hypertension by cardiologists in India. American J of Cardiology, in Press.
Pareek A, Ram CVS, Messerli F. Diuretics in hypertension --- A reappraisal. In Hypertension Reviews 2021 (Editor Ram CVS) Cardiological Society of India, Kolkata. Incessant Publications, Noida, India.
Ram CVS, Dani S, Oomman A, et al. Correlation between ambulatory blood pressure monitoring and office blood pressure measurement in patients with hypertension: A community study American Journal of Medical Sciences 2021;362:546-552.
Ram CVS, Iyengar SS, Wander GS, et al. Renal denervation therapy for hypertension: truths and half-truths. Asia Intervention 2021;7:62-68.

2022

Nadarajah R, Wu J, Hurdus B,, Asma S , Bhatt DL, Biondi-Zoccai G, , Mehta LS, Ram CVS, et al . The collateral damage of COVID-19 on cardiovascular services: state-of-the-art review with meta-analysis, in press 2022, European Heart Journal.
Ram CVS, Muppalla BS, Parthasarathi SV, et al. Achieving the Latest American Heart Association and American College of Cardiology Therapeutic Goals for Hypertension with Combination Therapy and its effects on Blood Pressure and Central Hemodynamic Parameters. American Journal of Cardiology 2022;168:78-82.
Ram CVS, Dalal J, Kahali D, et al. Management of American Heart Association / American College of Cardiology – Defined Stage 2 Hypertension by Cardiologists in India. Am J Cardiol. 2022;167:62-67.
Ram CVS. Renal denervation therapy for hypertension: all that glitters is not gold. Eur Heart J 2022 Feb 15.
Ram CVS, Amstein R, Luscher TF. Cardiology Update 21: A growing Indo-European educational platform to fight cardiovascular disease; European Heart Journal. 2022; 43:1528-1530.
Ram CVS, Mohan V, Pandit K, et al. Management of Hypertension in patients with Diabetes. A Comprehensive Review of the Perceptions and Practices of Health Care Providers in India. Journal of Association of Physicians of India. JAPI 2022;70:59-64.
Metri KG, Raghuram N, Ram CVS, et al. The Deadly Duo of Hypertension and Diabetes in India; Further Affirmation from a New Epidemiological Study. Journal of Association of Physicians of India. JAPI 2022;70:14-17.
Ram CVS. Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review. Cardiol Ther, August 2022. (doi.org/10.1007/s40119-022-00276-4).
Messerli FH, Bavishi C, Brguljan J, Burnier M, Dobner S, Elijovich F, Ferdinand KC, Kjeldsen S, Laffer C, Ram CVS, et al. Renal denervation in the antihypertensive arsenal—knowns and known unknowns. Journal of Hypertension 2022; 40:1859-1875.
Nadarajah R, Wu Jianhua, Hurdus B, Asma S, Bhatt DL, Biondi – Zoccai G, Mehta L S, Ram CVS, et al. The collateral damage of COVID-19 to cardiovascular services: a meta-analysis. European Heart Journal, 2022;43:3164-3178.

2023

Ram CVS. “Normal” blood pressure is no longer a safe haven: take shelter under “optimal” blood pressure. European Heart Journal, March 2023 (00), 1-2. doi.org / 10.1093 / eurheart / ehad 102.
Pareek A, Messerli FH, Ram CVS. Chlorthalidone vs Hydrochlorothiazide for Hypertension – CV Events: Did the design influence the outcome? Journal of Association of Physicians of India 2023:71:93.
Ram CVS. Physician, Heal Thyself: Thou Shalt Not Overlook Hypokalemia in Clinical Practice. American Journal of Medicine. 2023;136:963-964.
Ram CVS. The latest hypertension guidelines: from encryption to decryption, finally! Journal of Hypertension 2023;41:2072-2073.
Ram CVS, Wali M. Hypertension and cognitive impairment. In Cardiology Update 2023, Cardiological Society of India (Editor-in-chief Rath PC), pages 242-248. Jaypee Brothers Medical Publishers, New Delhi, India 2023.
Shalava E, Babadjanov J, Messerli FH, Ram CVS. The choice of a diuretic in the treatment of hypertension. An updated narrative. In Cardiology Update 2023, Cardiological Society of India (Editor-in-chief Rath PC), pages 278-285, Jaypee Brothers Medical Publishers, New Delhi, India 2023.

2024

Ram CVS, Wander GS. The latest hypertension guidelines at-a-glance: No need for a QR code. American J of Cardiology. 2024;213:173-175.
Ram CVS, Muruganathan A,Manjula S, et al. (April 01, 2024) Indian Clinician’s Perspective on the Approach to the Management of Hypertension: A Cross-Sectional Study. Cureus 16(4): e57435. DOI 10.7759/cureus.57435.
Pandey A, Keshvani N, Ram CVS. Systemic Hypertension. In Tandon’s Book of Cardiology, second edition (Editors – Prabhakaran D, Kumar RK, Naik N, Itchhaporia D), Walters Kluwer, New Delhi, India, Chapter 32, Pages 698-711, 2024.
Ram CVS. A New Class of Drugs Approved in the United States for Hypertension: Endothelin Antagonists. American Journal of Medicine 2024;137:795-798.
Ram CVS. Grappling with hypertension management in the old, very old, and frail patients: A double-edged sword, In Cardiology Update 2024 (Tyagi S, Editor), Cardiological Society of India. Chapter 48, pages 309-314, Jaypee Brothers, New Delhi, India, 2024.

2025

Ram CVS, Murad F, Kumar AS, et al. Elevated plasma nitrate levels in patients with acute coronary syndrome. The American J of Cardiology. 2025;240:68-70.
Messerli F, Ram CVS, Burnier M. Low-salt diet and thiazide diuretics. Circulation 2025;151: 1297-1298.
Ram CVS. Artificial intelligence: An emerging tool for the diagnosis and management of hypertension. In Cardiology Update 2025 / Cardiological Society of India (Editors, Kahali / Roy / Sinha). Jaypee Brothers, New Delhi, India. Pages 29-36.